If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 2.9 Announcement - Transaction in own shares

23 Nov 2022 07:00

RNS Number : 2782H
Allied Minds PLC
23 November 2022
 

23 November 2022

Allied Minds Plc

("the "Company")

 

Rule 2.9 Announcement - Transaction in own shares

 

Allied Minds plc (AIM: ALM, 'Allied Minds' or 'the Company') announces that, in accordance with the terms of its share buyback programme announced on 17 November 2022 ("Share Buyback Programme"), the Company purchased the following number of its Ordinary Shares of £0.01 each ("Ordinary Shares") through Numis Securities Limited. The Ordinary Shares purchased will be held in treasury until transferred by the Company to the directors and employees in satisfaction of awards under the 2014 Long Term Incentive Plan ("LTIP").

 

Date of purchase:

 22 November 2022

Volume of Allied Minds shares purchased:

231,044

Average market price paid per share (GBp):

9.4000

Highest price paid per share (GBp):

9.400

Lowest price paid per share (GBp):

9.400

 

In accordance with Rule 2.9 of The City Code on Takeovers and Mergers, Allied Minds confirms that, as at the date and time of this announcement, the remaining number of Ordinary Shares in issue will be 238,827,009 (excluding treasury shares), and the Company hold 823,264 Ordinary Shares in treasury. Therefore, the total voting rights in the Company will be 238,827,009. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The International Securities Identification Number for Allied Minds Ordinary Shares is GB00BLRLH124.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the table below contains detailed information of the individual trades made by Numis Securities Limited as part of the Share Buyback Programme.

 

Schedule of Purchases - Individual Transactions

 

Number of ordinary shares purchased

Transaction price(GBp share)

Time of transaction (UK Time)

Transaction reference number

Trading venue

20000

9.40

08:43:14

00062277550TRLO0

LSE

24099

9.40

08:43:14

00062277551TRLO0

LSE

14892

9.40

08:43:14

00062277552TRLO0

LSE

2708

9.40

08:43:14

00062277555TRLO0

LSE

6499

9.40

08:56:32

00062278105TRLO0

LSE

12939

9.40

09:34:16

00062279951TRLO0

LSE

1061

9.40

09:34:16

00062279952TRLO0

LSE

7000

9.40

10:12:49

00062281341TRLO0

LSE

8690

9.40

12:29:51

00062287199TRLO0

LSE

48442

9.40

12:29:51

00062287200TRLO0

LSE

16246

9.40

12:29:59

00062287212TRLO0

LSE

10000

9.40

12:30:02

00062287222TRLO0

LSE

5239

9.40

12:46:01

00062287784TRLO0

LSE

5186

9.40

15:22:31

00062296325TRLO0

LSE

8038

9.40

15:22:45

00062296338TRLO0

LSE

15000

9.40

16:16:27

00062300555TRLO0

LSE

46

9.40

16:17:38

00062300637TRLO0

LSE

24954

9.40

16:23:43

00062301225TRLO0

LSE

5

9.40

16:24:18

00062301266TRLO0

LSE

 

The Company will make further regulatory announcements to shareholders in respect of purchases of Ordinary Shares by the Company as they occur.

 

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

Allied Minds plc

c/o Instinctif Partners

JTC (UK) Limited - Company Secretary

Christopher Gibbons

0203 846 9774

christopher.gibbons@jtcgroup.com

Instinctif Partners - Communications

Tim Linacre / Rozi Morris / Joe Quinlan

 

alliedminds@instinctif.com

 

The Company's LEI is 213800YB4G7YN21NLL72

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTTUURARUSUAUUA
Date   Source Headline
16th Jul 20217:00 amRNSTransaction in Own Shares
13th Jul 20217:00 amRNSTransaction in Own Shares
7th Jul 20217:00 amRNSTransaction in Own Shares
5th Jul 20217:00 amRNSTransaction in Own Shares
2nd Jul 20217:00 amRNSTransaction in Own Shares
1st Jul 20217:00 amRNSTransaction in Own Shares
30th Jun 20217:00 amRNSTransaction in Own Shares
29th Jun 20217:00 amRNSTransaction in Own Shares
28th Jun 20217:00 amRNSTransaction in own shares
25th Jun 20217:00 amRNSTransaction in own shares
24th Jun 20217:00 amRNSTransaction in own shares
23rd Jun 20217:00 amRNSPortfolio company update and share buyback
16th Jun 20214:41 pmRNSSecond Price Monitoring Extn
16th Jun 20214:36 pmRNSPrice Monitoring Extension
3rd Jun 20214:41 pmRNSSecond Price Monitoring Extn
3rd Jun 20214:35 pmRNSPrice Monitoring Extension
1st Jun 20217:00 amRNSOcuTerra Therapeutics Series B Second Close
24th May 20214:41 pmRNSSecond Price Monitoring Extn
24th May 20214:36 pmRNSPrice Monitoring Extension
18th May 20214:40 pmRNSSecond Price Monitoring Extn
18th May 20214:35 pmRNSPrice Monitoring Extension
12th May 20215:28 pmRNSResult of AGM
11th May 20217:00 amRNSBlock listing Interim Review
11th May 20217:00 amRNSBlock listing Interim Review
11th May 20217:00 amRNSBlock listing Interim Review
28th Apr 20217:00 amRNSOcuTerra Therapeutics Raises Series B Financing
15th Apr 20217:00 amRNSBlock Listing Application
13th Apr 20217:00 amRNSOrbital Sidekick Closes $16m Series A Financing
9th Apr 20217:00 amRNSCapital Markets Day
6th Apr 20217:00 amRNSNotice of AGM
1st Apr 20215:34 pmRNSHolding(s) in Company
30th Mar 20217:00 amRNSAnnual results release
29th Mar 20214:28 pmRNSHolding(s) in Company
22nd Mar 20217:00 amRNSNotice of results - update
18th Mar 20214:41 pmRNSSecond Price Monitoring Extn
18th Mar 20214:36 pmRNSPrice Monitoring Extension
11th Mar 20214:36 pmRNSPrice Monitoring Extension
1st Mar 20219:00 amRNSNotice of Results
23rd Feb 20217:00 amRNSBridgeComm Advances Development of MOCA Technology
2nd Feb 20219:33 amRNSDirector/PDMR Shareholding
22nd Jan 20214:36 pmRNSPrice Monitoring Extension
15th Jan 20217:00 amRNSDirectorate Change
8th Jan 20214:36 pmRNSPrice Monitoring Extension
4th Jan 20215:15 pmRNSHolding(s) in Company
4th Jan 20217:00 amRNSStrategic update
24th Dec 20207:00 amRNSOrbital Sidekick Series A Financing
21st Dec 20203:25 pmRNSFederated Wireless partners with TESSCO
1st Dec 20203:35 pmRNSTotal Voting Rights
23rd Nov 20204:36 pmRNSPrice Monitoring Extension
19th Nov 20207:00 amRNSShareholder engagement update on 2020 AGM vote

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.